Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-08-13Clinical Trial Update: Post Marketing Surveillance Study to Evaluate the Tolerability of Rebif® New Formulation in Patients With Relapsing Multiple Sclerosis in an Australian Clinical Setting.
A post-marketing surveillance study assessed the tolerability of Rebif's new formulation in relapsing multiple sclerosis patients in Austral…
-
CLINICAL_TRIALS trial_result · 2014-08-11Clinical Trial Update: Pregnancy Exposure Registry for Tysabri®
The Pregnancy Exposure Registry for natalizumab (Tysabri) has completed data collection, documenting outcomes in patients with Crohn's disea…
-
CLINICAL_TRIALS trial_result · 2014-07-31Clinical Trial Update: Pharmacogenetic Trial and Long-term Follow-up of the PRISMS Trial (PRISMS-15)
A completed pharmacogenetic trial and long-term follow-up of the PRISMS trial in multiple sclerosis. The study was sponsored by Merck KGaA.
-
CLINICAL_TRIALS trial_result · 2014-07-31Clinical Trial Update: To Identify and Evaluate the Predictive Factors for Depression in Patients Diagnosed With Multiple Sclerosis
This completed clinical trial, sponsored by Merck KGaA, evaluated factors that predict depression in patients with Multiple Sclerosis.
-
CLINICAL_TRIALS trial_result · 2014-07-31Clinical Trial Update: Rebif Compliance Support Program - Assessing Needs in Multiple Sclerosis
This clinical trial update notes the completed Rebif Compliance Support Program study assessing needs in people with Multiple Sclerosis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: Mobility Enhancing Nursing Intervention [NA]
This entry reports the completion status of a clinical trial evaluating a mobility-enhancing nursing intervention for stroke and multiple sc…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: An Observational Study Comparing Multiple Sclerosis International Quality of Life Questionnaire (MusiQoL) and Multiple Sclerosis Quality of Life-54 Instrument (MSQOL-54) in Relapsing Multiple Sclerosis (RMS) Patients on Long-term Rebif® Therapy
This document reports results from a completed observational study comparing two quality-of-life instruments (MusiQoL and MSQOL-54) in relap…
-
CLINICAL_TRIALS trial_result · 2014-07-11Clinical Trial Update: An Observational Study to Document the Effectiveness and Compatibility of Rebif 44 or 22 µg in the Therapy of the Chronic Multiple Sclerosis
An observational study evaluating the effectiveness and tolerability of Rebif 44 µg or 22 µg in chronic multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: Evaluation of Brain Atrophy in CIS Patients on Avonex
A completed clinical trial evaluated brain atrophy in patients with clinically isolated syndrome who were treated with Avonex (interferon be…
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: Treatment Adherence When Using RebiSmart™ in Relapsing Multiple Sclerosis Subjects
This completed trial update reports on treatment adherence outcomes for relapsing multiple sclerosis patients using the RebiSmart autoinject…
-
CLINICAL_TRIALS trial_result · 2014-07-04Clinical Trial Update: Open Label Extension Study to Evaluate the Safety and Tolerability of Oral Fampridine-Sustained Release (SR) in Canadian Participants With Multiple Sclerosis Who Participated in Acorda Extension Trials. [Phase 3]
This is an open-label extension study in Canadian participants with multiple sclerosis evaluating safety and tolerability of oral dalfamprid…
-
CLINICAL_TRIALS trial_result · 2014-06-27Clinical Trial Update: Use of Two Deep Brain Stimulation (DBS) Electrodes to Treat Post-Traumatic Tremor [NA]
An update on a clinical trial evaluating two deep brain stimulation electrodes to treat post-traumatic tremor, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-06-16Clinical Trial Update: Dalfampridine for Imbalance in Multiple Sclerosis [Phase 2]
Phase 2 trial results of dalfampridine (Ampyra) for imbalance in people with multiple sclerosis were posted in 2014. The study evaluated out…
-
CLINICAL_TRIALS trial_result · 2014-06-13Clinical Trial Update: Peginterferon Beta-1a (BIIB017) Autoinjector Pharmacokinetic Study in Healthy Volunteers [Phase 1]
Phase 1 pharmacokinetic study of the pegylated interferon beta-1a autoinjector (BIIB017) was conducted in healthy volunteers to assess its P…
-
CLINICAL_TRIALS trial_result · 2014-06-09Clinical Trial Update: Pregnancy Exposure Registry for Avonex (Interferon Beta-1a)
This clinical trial update notes the completion of Avonex's pregnancy exposure registry (interferon beta-1a). It is used to monitor prenatal…
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: Optical Coherence Tomography in Multiple Sclerosis Patients
This clinical trial update notes that a study evaluating optical coherence tomography in patients with multiple sclerosis and optic neuritis…
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: Aspirin for Treatment of Multiple Sclerosis-Related Fatigue [Phase 3]
A Phase 3 trial of aspirin for treatment of multiple sclerosis-related fatigue was terminated, and the results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-05-07Clinical Trial Update: Immunogenicity and Safety of Subcutaneously-administered Avonex (Interferon Beta-1a) in Multiple Sclerosis (MS) Patients [Phase 3]
A Phase 3 trial evaluating the immunogenicity and safety of subcutaneously administered Avonex (Interferon beta-1a) in multiple sclerosis pa…
-
CLINICAL_TRIALS trial_result · 2014-05-06Clinical Trial Update: Influence of High Intensity Exercise on Insulin Resistance, Muscle Contractile Properties, Aerobic Capacity and Body Composition in Multiple Sclerosis [NA]
This entry reports the completed clinical trial evaluating the effects of high-intensity exercise on insulin resistance, muscle contractile …
-
CLINICAL_TRIALS trial_result · 2014-05-05Clinical Trial Update: Trial of Ginkgo as a Treatment for Cognitive Problems in Multiple Sclerosis [Phase 2]
Phase 2 trial evaluating ginkgo biloba extract for cognitive problems in multiple sclerosis has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: A Randomized Study of Sativex on Cognitive Function and Mood: Multiple Sclerosis Patients [Phase 4]
Phase 4 randomized trial assessing Sativex for cognitive function and mood in multiple sclerosis patients with spasticity; study completed w…
-
CLINICAL_TRIALS trial_result · 2014-05-01Clinical Trial Update: Hematopoietic Stem Cell Therapy for Patients With Multiple Sclerosis [Phase 1, Phase 2]
This clinical trial update reports on Phase 1/Phase 2 autologous hematopoietic stem cell therapy for multiple sclerosis; the study was termi…
-
CLINICAL_TRIALS trial_result · 2014-04-10Clinical Trial Update: Task-oriented Circuit Class Training in Multiple Sclerosis Subjects [NA]
This entry notes the completion of a clinical trial evaluating task-oriented circuit class training for individuals with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: Neuroprotection With Riluzole Patients With Early Multiple Sclerosis [Phase 2]
Phase 2 trial evaluating riluzole for neuroprotection in early multiple sclerosis has completed, and results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: Effects of Targeted Lower Extremity Joint Training on Multiple Sclerosis (MS) Gait Abnormalities [NA]
The clinical trial update reports the completion of a study evaluating targeted lower-extremity joint training for improving gait abnormalit…